Commission Gets Active Again In The Pharmaceutical Sector: First-Ever Cartel Decision In Relation To An Active Pharmaceutical Ingredient (JSON)

lexblog.com/lib/2KPPP7V8view recordjson

{
    "@context": "https://schema.org",
    "@type": "Article",
    "headline": "Commission Gets Active Again In The Pharmaceutical Sector: First-Ever Cartel Decision In Relation To An Active Pharmaceutical Ingredient",
    "url": "https://www.lexblog.com/2023/10/19/commission-gets-active-again-in-the-pharmaceutical-sector-first-ever-cartel-decision-in-relation-to-an-active-pharmaceutical-ingredient/",
    "identifier": {
        "@type": "PropertyValue",
        "name": "LexBlog Library record",
        "value": "LEX-WK-2KPPP7V8",
        "url": "https://www.lexblog.com/lib/2KPPP7V8/"
    },
    "datePublished": "2023-10-19T11:26:00-04:00",
    "dateModified": "2023-12-19T08:44:56-05:00",
    "author": {
        "@type": "Person",
        "name": "Liam Rowley, Kristi Georgieva, Julia Blanco"
    },
    "sourceOrganization": {
        "@type": "Organization",
        "name": "Cleary Gottlieb Steen & Hamilton LLP"
    },
    "organizationScope": "at-publication",
    "isPartOf": "Cleary Antitrust Watch",
    "about": "Antitrust, Competition and Trade",
    "sourceUrl": "https://www.clearyantitrustwatch.com/?p=5584",
    "sourceStability": "may-move"
}